Sherry Aulin
Fortuna: - $ al 31/10/2026
Fortuna: - $ al 31/10/2026
Ms. Sherry Aulin, CPA, is on the Board of Directors at Defence Therapeutics Inc. Ms. Aulin was previously employed as a Chief Financial Officer by Xenon Pharmaceuticals, Inc. and a Senior Manager by KPMG LLP (Canada).
She received her undergraduate degree from the University of British Columbia.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 29/09/2026 | 0 ( -.--% ) | - $ | 31/10/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| DEFENCE THERAPEUTICS INC. | Director/Miembro de la Junta | 29/09/2026 |
| Empresas | Cargo | Fin |
|---|---|---|
| XENON PHARMACEUTICALS INC. | Director Financiero/CFO | 30/06/2025 |
KPMG LLP (Canada)
KPMG LLP (Canada) Miscellaneous Commercial ServicesCommercial Services Provides audit, tax and advisory services | Corporate Officer/Principal | 01/01/2011 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Xenon Pharmaceuticals, Inc.
Xenon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovering, developing and delivering of therapeutics for neurological & psychiatric disorders | Health Technology |
University of British Columbia
University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
KPMG LLP (Canada)
KPMG LLP (Canada) Miscellaneous Commercial ServicesCommercial Services Provides audit, tax and advisory services | Commercial Services |
Defence Therapeutics Inc
Defence Therapeutics Inc Pharmaceuticals: MajorHealth Technology Engages in the research and development of anti-body drug conjugates | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.